GlassScriptPhysician profile
Luxman Srikantha
NPI 1679932479
$1,902.69
in general payments reported to CMS, 2019-2025
9 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
See the full distribution for Plastic Surgery within the Head & Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.33 · 2022: $1,367 · 2024: $165 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421 · Education: $15.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.04 |
| Education | $15.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,367.36 | 2022 | |
| Inspire Medical Systems, INC. | $137.99 | 2024-2025 | Inspire |
| Zoll Respicardia, INC. | $88.89 | 2025 | Remede System |
| Glaxosmithkline, LLC. | $79.01 | 2025 | Nucala |
| Intersect Ent, INC. | $73.71 | 2021 | |
| Genzyme Corporation | $46.25 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $40.71 | 2024 | Dupixent, Libtayo |
| Acclarent, INC | $39.92 | 2021-2024 | Acclarent Aera |
| Sanofi US Services INC. | $28.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luxman Srikantha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.